Aker BioMarine ASA (OSL:AKBM) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:AKBM Aker BioMarine ASA OSL:AKBM
64 GF Score
Price kr109.00
GF Value kr74.55
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aker BioMarine ASA FFO?

FFO (Funds from operations) only applies to REITs.

OSL:AKBM
64GF Score
Aker BioMarine ASA OSL:AKBM
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aker BioMarine ASA (OSL:AKBM) Overvalued in 2026?

Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued. The current stock price of kr109.00 is trading 46.2% above its estimated GF Value™ of kr74.55. GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.

Key valuation signals for OSL:AKBM:

  • FFO:
  • GF Value™: kr74.55 vs. price of kr109.00 (46.2% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the OSL:AKBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aker BioMarine ASA Business Description

Other Exchanges AKBMo:Sweden1PG:Germany
Address Oksenoyveien 10, Lysaker, NOR, 1366
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
64GF Score

Get the complete analysis for OSL:AKBM

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr109.00
Price
kr74.55
GF Value